Cargando…

HTA17 Cost-Effectiveness Analysis of Tocilizumab for The Treatment of COVID-19 in Hospitalised Patients on Corticosteroids, From the Italian NHS Perspective

Detalles Bibliográficos
Autores principales:	Jovanoski, N, Dario, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747502/ http://dx.doi.org/10.1016/j.jval.2022.09.1477

Ejemplares similares

Healthcare Services for Undocumented Migrants: Organisation and Costs from the Italian NHS Perspective
por: Listorti, Elisabetta, et al.
Publicado: (2022)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

Research to meet the needs of the NHS: a review of published NIHR HTA clinical trials
por: Young, Amanda, et al.
Publicado: (2011)

HTA56 COVID-19 from the Perspective of Intellectual Property
por: Pereira da Veiga, CR, et al.
Publicado: (2022)

Impact of corticosteroids in hospitalised COVID-19 patients
por: Ho, Kam Sing, et al.
Publicado: (2021)

HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
por: Garagiola, Elisabetta, et al.
Publicado: (2020)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

Worldwide HTA access to ICER's cost-effectiveness models
Publicado: (2020)

How the Italian NHS Is Fighting Against the COVID-19 Emergency
por: Boccia, Stefania, et al.
Publicado: (2020)

The Italian NHS: What Lessons to Draw from COVID-19?
por: Garattini, Livio, et al.
Publicado: (2020)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

HTA assessment of COVID-19 interventions in Ireland
Publicado: (2020)

Patient advocate perspectives on involvement in HTA: an international snapshot
por: Scott, Anna Mae, et al.
Publicado: (2017)

Le tocilizumab pour les patients hospitalisés atteints de la COVID-19
por: Afra, Kevin, et al.
Publicado: (2021)

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
por: Tafuri, Giovanni, et al.
Publicado: (2016)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?”
por: Golinelli, Davide, et al.
Publicado: (2020)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia
por: AlQahtani, Hajar, et al.
Publicado: (2022)

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023)

The Italian NHS in Lombardy and Veneto: near but far
por: Garattini, Livio, et al.
Publicado: (2021)

The Structures and Activities of Health Promotion in the Italian NHS
por: Bosco, Roberta, et al.
Publicado: (2023)

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus
por: Torre, Enrico, et al.
Publicado: (2021)

Ethical analysis in HTA of complex health interventions
por: Lysdahl, Kristin Bakke, et al.
Publicado: (2016)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Alkofide, Hadeel, et al.
Publicado: (2021)

Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19()
por: Kawamata, Takaya, et al.
Publicado: (2022)

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
por: Kardos, Zsófia, et al.
Publicado: (2023)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

[Translated article] Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients
por: Garcia-Molina, A., et al.
Publicado: (2023)

P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective
por: Mycka, J, et al.
Publicado: (2022)

POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ba26isjdlb5tecndukunanmrou